PacBio’s Highly Accurate HiFi Sequencing Will Help Clinical Researchers Identify Disease-Causing Genetic Variants and Increase Our Understanding of Rare Diseases KANSAS CITY, Mo. and MENLO PARK, Calif., Feb. 24, 2021…
Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S. MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading…
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2020. Reported…
MENLO PARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”), a leading provider of high-quality, long-read sequencing platforms, today announced that SB…
MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes,…
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes,…
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results…
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results…
New Platform Expected to Make Whole Genome Sequencing Significantly More Affordable and Accessible for Use in Mainstream Medical Care MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences…
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms,…
MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announced unaudited preliminary revenue…
MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van…
Seven New Sequel IIe Systems Will Support Expanded Generation of High-Quality Genomes for Improving Fundamental Understanding of Biology and Aiding Biodiversity Conservation MENLO PARK, Calif ., Jan. 08, 2021 (GLOBE…
MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes,…
Presentation at the American Society for Microbiology NGS Conference Highlights Utility of PacBio’s Highly Accurate Long-Read Sequencing Platform in Disease Surveillance MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) —…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.